Trial · NCT02097485
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
NCT02097485, Phase 2, Completed, Dr. Reddy's Laboratories Limited, India; results first posted 2021-05-11
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation. Trials, record NCT02097485. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02097485
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
- NCT number
- NCT02097485
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 50 participants, actual
- Lead sponsor
- Dr. Reddy's Laboratories Limited, India
- Conditions
- Head Lice Infestation
- Interventions
- Abametapir Lotion 0.74% w/w, Vehicle Lotion
- First posted
- 2014-03-27
- Last updated
- 2021-05-11
- Results first posted
- 2021-05-11
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment | 14 days | Percentage of hatched eggs pre treatment relative to percentage of hatched eggs post treatment for the abametapir and vehicle treated eggs following 14 day incubation. The difference between post treatment percent hatching and pre-treatment percent hatching was calculated i.e. post-treatment minus pre-treatment hatching percent. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment | 14 days | Full Analysis Set (FAS) included all randomized subjects who received any amount of study treatment and had at least 1 viable pre-treatment egg and 1 viable post-treatment egg evaluable for analysis. | Percent hatched eggs post versus pre Rx | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment | Abametapir Lotion 0.74% w/w | -92.9 | 95% Confidence Interval -99.4 to -86.5 | Percent hatched eggs post versus pre Rx | |
| Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment | Vehicle Lotion | -42.3 | 95% Confidence Interval -54.4 to -30.2 | Percent hatched eggs post versus pre Rx |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Abametapir Lotion 0.74% w/w | 25 | |
| Overall Study | STARTED | Vehicle Lotion | 25 | |
| Overall Study | COMPLETED | Abametapir Lotion 0.74% w/w | 25 | |
| Overall Study | COMPLETED | Vehicle Lotion | 25 | |
| Overall Study | NOT COMPLETED | Abametapir Lotion 0.74% w/w | 0 | |
| Overall Study | NOT COMPLETED | Vehicle Lotion | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rash | Skin and subcutaneous tissue disorders | Abametapir Lotion 0.74% w/w | 4 | 25 | 4 |
| other | Rash | Skin and subcutaneous tissue disorders | Vehicle Lotion | 2 | 25 | 2 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Abametapir Lotion 0.74% w/w | 0 | 25 |
| Total, all-cause mortality | Vehicle Lotion | 0 | 25 |
| Total, other adverse events | Abametapir Lotion 0.74% w/w | 4 | 25 |
| Total, other adverse events | Vehicle Lotion | 2 | 25 |
| Total, serious adverse events | Abametapir Lotion 0.74% w/w | 0 | 25 |
| Total, serious adverse events | Vehicle Lotion | 0 | 25 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Abametapir Lotion 0.74% w/w vs Vehicle Lotion: deaths from any cause | Trial comparisons |
| Abametapir Lotion 0.74% w/w vs Vehicle Lotion: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02097485
GET https://conductscience.org/api/trials/v1/NCT02097485/registered